Advertisement

Recent trends in the management of invasive vulval cancer

Published:November 08, 2022DOI:https://doi.org/10.1016/j.ogrm.2022.10.003

      Abstract

      Vulval cancer is a rare gynaecological cancer, predominantly seen in postmenopausal women. It accounts for about 4% of gynaecological malignancies. Most women present with vulval symptoms such as a painful lump, ulcer or itching, although some may be asymptomatic. It should be managed in experienced cancer centres where relevant expertise and experience is available to provide multidisciplinary, individualized care. Wide local excision of the lesion, usually with surgical staging of groin nodes through separate incisions is recommended for early disease. Locally advanced vulval cancers require complex and highly individualized treatment, which may be a combination of radical excision with reconstruction with or without radiotherapy. Sentinel lymph node assessment for staging is now standard of care, replacing en-bloc inguinofemoral lymphadenectomy for surgical staging of smaller, early-stage tumours, and groin dissection is omitted in these women if sentinel node biopsy is negative (GROINSS-V I study). Recent GROINSS-V II study has shown that radiotherapy is a safe alternative in patients with sentinel lymph node micro metastases (≤2 mm) with low groin recurrence rate and lower treatment-related morbidity.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Obstetrics, Gynaecology and Reproductive Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      Further reading

        • Covens A.
        • Vella E.T.
        • Kennedy E.B.
        • Reade C.J.
        • Jimenez W.
        • Le T.
        Sentinel lymph node biopsy in vulvar cancer: systematic review, meta-analysis, and guideline recommendations.
        Gynecol Oncol. 2015 May 1; 137: 351-361
        • Hacker N.F.
        Vulval cancer.
        in: Berek J.S. Hacker N.F. Berek and Hacker's gynecologic oncology. Lippincott Williams & Wilkins, 2010: 576-592
        • Morrison J.
        • Baldwin P.
        • Buckley L.
        • et al.
        British Gynaecological Cancer Society (BGCS) vulval cancer guidelines: recommendations for practice.
        Eur J Obstet Gynecol Reprod Biol. 2020 Sep; 252: 502-525
        • Oonk M.H.
        • Slomovitz B.
        • Baldwin P.J.
        • et al.
        Radiotherapy versus inguinofemoral lymphadenectomy as treatment for vulvar cancer patients with micrometastases in the sentinel node: results of GROINSS-V II.
        J Clin Oncol. 2021 Nov 10; 39: 3623-3632
      1. Shafi M. Bolton H. Gajjar K. Gynaecological oncology for the MRCOG. Cambridge University Press, 2018 Apr 19
        • te Grootenhuis N.C.
        • Van Der Zee A.G.
        • Van Doorn H.C.
        • et al.
        Sentinel nodes in vulvar cancer: long-term follow-up of the Groningen International Study on Sentinel nodes in Vulvar cancer (GROINSS-V) I.
        Gynecol Oncol. 2016 Jan 1; 140: 8-14